These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent. Ishibashi Y, Muramatsu T, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Cho YK, Garcia-Garcia HM, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, McClean D, de Sousa Almeida M, Wasungu L, Miquel-Hebert K, Dudek D, Chevalier B, Onuma Y, Serruys PW. JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444 [Abstract] [Full Text] [Related]
13. Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents. Tandjung K, Basalus MW, Muurman E, Louwerenburg HW, van Houwelingen KG, Stoel MG, de Man FH, Jansen H, Huisman J, Linssen GC, Droste HT, Nienhuis MB, von Birgelen C. Catheter Cardiovasc Interv; 2012 Oct 01; 80(4):524-30. PubMed ID: 22109857 [Abstract] [Full Text] [Related]
14. Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival. Lee PH, Lee SW, Park HS, Kang SH, Bae BJ, Chang M, Roh JH, Yoon SH, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ. JACC Cardiovasc Interv; 2016 Mar 28; 9(6):530-8. PubMed ID: 26947387 [Abstract] [Full Text] [Related]
15. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study. Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY. Catheter Cardiovasc Interv; 2015 Mar 28; 85 Suppl 1():762-9. PubMed ID: 25630513 [Abstract] [Full Text] [Related]
16. Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial. van Houwelingen KG, Sen H, Lam MK, Tandjung K, Löwik MM, de Man FH, Louwerenburg JH, Stoel MG, Hartmann M, Linssen GC, Doggen CJ, von Birgelen C. Catheter Cardiovasc Interv; 2015 Feb 15; 85(3):E76-82. PubMed ID: 25339110 [Abstract] [Full Text] [Related]
18. Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion. Lee SW, Lee JY, Park DW, Kim YH, Yun SC, Kim WJ, Suh J, Cho YH, Lee NH, Kang SJ, Lee CW, Park SW, Park SJ. Catheter Cardiovasc Interv; 2011 Sep 01; 78(3):346-53. PubMed ID: 21452248 [Abstract] [Full Text] [Related]
20. Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion. Lee PH, Lee SW, Yun SC, Bae J, Ahn JM, Park DW, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ. JACC Cardiovasc Interv; 2017 Jul 24; 10(14):1405-1412. PubMed ID: 28668311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]